Your browser is no longer supported. Please, upgrade your browser.
GH [NASD]
Guardant Health, Inc.
Index- P/E- EPS (ttm)-2.58 Insider Own2.40% Shs Outstand100.04M Perf Week-4.70%
Market Cap15.08B Forward P/E- EPS next Y-2.88 Insider Trans-54.06% Shs Float94.16M Perf Month2.69%
Income-253.80M PEG- EPS next Q-0.89 Inst Own88.30% Short Float5.26% Perf Quarter-6.55%
Sales286.70M P/S52.59 EPS this Y-211.70% Inst Trans2.41% Short Ratio5.13 Perf Half Y47.99%
Book/sh12.98 P/B11.52 EPS next Y16.00% ROA-17.60% Target Price177.80 Perf Year101.99%
Cash/sh17.79 P/C8.40 EPS next 5Y12.60% ROE-23.70% 52W Range71.41 - 181.07 Perf YTD15.98%
Dividend- P/FCF- EPS past 5Y- ROI-12.10% 52W High-17.45% Beta-
Dividend %- Quick Ratio27.90 Sales past 5Y- Gross Margin67.70% 52W Low109.31% ATR6.35
Employees864 Current Ratio28.30 Sales Q/Q24.50% Oper. Margin-88.90% RSI (14)47.10 Volatility3.47% 4.45%
OptionableYes Debt/Eq0.00 EPS Q/Q-249.50% Profit Margin-88.50% Rel Volume0.64 Prev Close152.92
ShortableYes LT Debt/Eq0.62 EarningsMay 06 AMC Payout- Avg Volume965.38K Price149.47
Recom1.30 SMA20-1.10% SMA50-1.80% SMA20023.30% Volume615,004 Change-2.26%
Jan-11-21Initiated Stifel Buy $175
Sep-09-20Initiated Morgan Stanley Overweight $110
Jun-12-20Initiated BTIG Research Buy
Feb-21-20Initiated Guggenheim Buy $103
Jan-07-20Initiated Citigroup Buy $100
Aug-07-19Reiterated Canaccord Genuity Buy $96 → $125
Apr-16-19Initiated Canaccord Genuity Buy $90
Apr-10-19Upgrade BofA/Merrill Neutral → Buy $81 → $84
Feb-28-19Reiterated BofA/Merrill Neutral $42 → $60
Oct-29-18Initiated William Blair Outperform
Oct-29-18Initiated JP Morgan Overweight $42
Oct-29-18Initiated BofA/Merrill Neutral $37
Apr-12-21 04:05PM  
07:26AM  
Apr-10-21 08:35AM  
Apr-06-21 11:11AM  
05:05AM  
Apr-01-21 11:05AM  
08:05AM  
06:57AM  
Mar-30-21 08:05AM  
Mar-26-21 08:05AM  
Mar-25-21 07:01AM  
Mar-24-21 08:05AM  
Mar-23-21 10:02AM  
Mar-21-21 07:33AM  
Mar-13-21 07:18AM  
Mar-04-21 03:21PM  
Mar-03-21 08:17AM  
Mar-02-21 08:05AM  
Mar-01-21 09:20AM  
Feb-25-21 11:34AM  
06:04AM  
12:30AM  
Feb-24-21 04:29PM  
04:05PM  
Feb-23-21 10:24AM  
Feb-21-21 06:17AM  
06:12AM  
Feb-17-21 04:03PM  
Feb-16-21 08:05AM  
Feb-12-21 06:01AM  
Feb-05-21 05:52AM  
Feb-04-21 04:03PM  
Feb-03-21 06:10AM  
Jan-29-21 06:08AM  
Jan-27-21 08:05AM  
Jan-25-21 06:01AM  
Jan-18-21 03:00AM  
Jan-14-21 08:05AM  
Jan-13-21 07:25AM  
Jan-07-21 01:18PM  
Jan-06-21 02:47AM  
Dec-30-20 04:03PM  
Dec-27-20 07:31AM  
Dec-24-20 10:21AM  
Dec-18-20 06:04AM  
Dec-15-20 02:35PM  
Dec-11-20 05:00PM  
Dec-08-20 12:32PM  
08:03AM  
Dec-07-20 08:05AM  
Nov-27-20 06:09AM  
Nov-16-20 11:22PM  
06:45PM  
06:47AM  
Nov-13-20 08:30AM  
Nov-07-20 09:43AM  
06:30AM  
12:31AM  
Nov-05-20 05:25PM  
04:03PM  
Nov-03-20 10:12AM  
Oct-30-20 09:42AM  
Oct-29-20 12:35PM  
Oct-27-20 03:03PM  
12:03PM  
Oct-17-20 07:14AM  
Oct-16-20 04:05PM  
Oct-15-20 04:05PM  
06:01AM  
Oct-12-20 08:14AM  
06:04AM  
Oct-07-20 03:14PM  
10:22AM  
09:06AM  
Oct-06-20 04:54PM  
Oct-05-20 04:05PM  
Sep-29-20 12:37PM  
07:27AM  
06:30AM  
Sep-26-20 06:16AM  
Sep-21-20 04:27PM  
Sep-16-20 06:19AM  
Sep-15-20 08:17AM  
Sep-11-20 02:10PM  
Sep-09-20 03:54PM  
Sep-03-20 06:08AM  
Sep-01-20 04:03PM  
07:00AM  
Aug-29-20 08:00AM  
Aug-28-20 06:08AM  
Aug-26-20 07:09AM  
Aug-24-20 04:15PM  
08:05AM  
Aug-11-20 06:40AM  
Aug-10-20 01:24PM  
08:05AM  
Aug-07-20 02:25PM  
Aug-06-20 08:30PM  
06:07PM  
04:03PM  
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing tests from its LUNAR program for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; LUNAR-2 test for the early detection of cancer in asymptomatic individuals eligible for cancer screening; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for residual disease and recurrence monitoring; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eltoukhy HelmyChief Executive OfficerApr 19Sale152.9750,9327,790,9141,908,267Apr 19 07:14 PM
Eltoukhy HelmyChief Executive OfficerApr 16Sale158.3451,1238,094,7211,959,199Apr 19 07:14 PM
Eltoukhy HelmyChief Executive OfficerApr 15Sale158.85157,10724,957,0962,010,322Apr 19 07:14 PM
Eltoukhy HelmyChief Executive OfficerApr 14Sale156.5460,9829,545,8742,167,429Apr 14 06:08 PM
Eltoukhy HelmyChief Executive OfficerApr 13Sale156.72105,80616,581,4452,228,411Apr 14 06:08 PM
MERESMAN STANLEY JDirectorApr 12Option Exercise5.944,93429,3088,993Apr 14 06:06 PM
MERESMAN STANLEY JDirectorApr 12Sale153.744,934758,5334,059Apr 14 06:06 PM
Eltoukhy HelmyChief Executive OfficerApr 12Sale154.5972,86111,263,8462,334,217Apr 14 06:08 PM
Eltoukhy HelmyChief Executive OfficerApr 09Sale156.8660,9969,567,6782,407,078Apr 09 05:51 PM
Eltoukhy HelmyChief Executive OfficerApr 08Sale160.78122,84619,751,1862,468,074Apr 09 05:51 PM
Eltoukhy HelmyChief Executive OfficerApr 07Sale158.6136,8435,843,6842,590,920Apr 09 05:51 PM
Kaul SamirDirectorApr 05Sale158.565,000792,78919,943Apr 07 05:08 PM
CLARK IAN TDirectorMar 25Option Exercise4.185382,2495,181Mar 29 05:13 PM
CLARK IAN TDirectorMar 25Sale132.0953871,0644,643Mar 29 05:13 PM
MERESMAN STANLEY JDirectorMar 10Option Exercise5.944,93429,3088,993Mar 12 05:25 PM
MERESMAN STANLEY JDirectorMar 10Sale137.854,934680,1524,059Mar 12 05:25 PM
CLARK IAN TDirectorFeb 25Option Exercise4.185382,2495,181Mar 01 05:09 PM
CLARK IAN TDirectorFeb 25Sale154.0053882,8524,643Mar 01 05:09 PM
Talasaz AmirAliChairman, President and COOFeb 11Sale166.98202,25133,771,3581,725,422Feb 12 08:19 PM
Talasaz AmirAliChairman, President and COOFeb 11Sale166.5623,5293,918,993477,413Feb 12 08:19 PM
Talasaz AmirAliChairman, President and COOFeb 11Sale168.466,6131,114,042470,800Feb 12 08:21 PM
MERESMAN STANLEY JDirectorFeb 10Option Exercise5.944,93429,3088,993Feb 12 04:53 PM
MERESMAN STANLEY JDirectorFeb 10Sale162.714,934802,8114,059Feb 12 04:53 PM
Talasaz AmirAliChairman, President and COOFeb 10Sale160.9058,3049,381,0701,927,673Feb 12 08:19 PM
Talasaz AmirAliChairman, President and COOFeb 10Sale160.908,6891,398,054500,942Feb 12 08:19 PM
Talasaz AmirAliChairman, President and COOFeb 09Sale162.93101,11116,474,2641,985,632Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 09Sale162.9315,0692,455,231509,631Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 08Sale162.3992,70815,054,4272,086,743Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 08Sale162.3913,8172,243,679524,700Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 05Sale161.76201,86132,653,5292,179,451Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 05Sale161.7630,0844,866,462538,517Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 04Sale158.7547,0537,469,8352,381,312Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 04Sale158.756,9701,106,512568,601Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 03Sale158.7276,91512,207,7722,428,365Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 03Sale158.7211,4621,819,222575,571Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 02Sale158.16130,89320,702,2292,622,883Feb 03 07:33 PM
Talasaz AmirAliChairman, President and COOFeb 02Sale158.1619,4983,083,832587,033Feb 03 07:33 PM
Talasaz AmirAliChairman, President and COOFeb 01Sale154.4195,74414,784,2392,753,776Feb 03 07:33 PM
Talasaz AmirAliChairman, President and COOFeb 01Sale154.4114,2692,203,337606,531Feb 03 07:33 PM
CLARK IAN TDirectorJan 25Option Exercise4.185382,2495,181Jan 27 05:00 PM
Eltoukhy HelmyChief Executive OfficerJan 25Sale157.2658,8119,248,6422,627,763Jan 26 05:40 PM
CLARK IAN TDirectorJan 25Sale162.0053887,1564,643Jan 27 05:00 PM
Eltoukhy HelmyChief Executive OfficerJan 22Sale159.91102,07516,322,4042,686,574Jan 26 05:40 PM
Eltoukhy HelmyChief Executive OfficerJan 21Sale162.01173,20628,061,5252,788,649Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 20Sale163.53167,66327,418,4732,961,855Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 20Sale163.5344,5287,281,807365,775Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 19Sale160.12103,71716,606,912410,303Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 15Sale158.39150,00023,758,873514,020Jan 19 04:59 PM
MERESMAN STANLEY JDirectorJan 11Option Exercise5.944,93429,3088,993Jan 13 04:40 PM
MERESMAN STANLEY JDirectorJan 11Sale142.004,934700,6284,059Jan 13 04:40 PM
CLARK IAN TDirectorJan 04Option Exercise4.182,69011,2447,333Jan 06 04:18 PM
CLARK IAN TDirectorJan 04Sale129.232,690347,6294,643Jan 06 04:18 PM
Talasaz AmirAliChairman, President and COOJan 01Option Exercise0.00565,19203,128,647Jan 05 08:42 PM
Eltoukhy HelmyChief Executive OfficerJan 01Option Exercise0.00565,19203,408,645Jan 05 08:44 PM
CLARK IAN TDirectorDec 28Option Exercise4.185382,2495,181Dec 30 04:30 PM
CLARK IAN TDirectorDec 28Sale135.0053872,6304,643Dec 30 04:30 PM
Talasaz AmirAliChairman, President and COODec 21Option Exercise4.1823,92399,9982,563,455Dec 23 04:50 PM
Eltoukhy HelmyChief Executive OfficerDec 16Option Exercise4.1823,92399,9982,843,453Dec 18 04:57 PM
MERESMAN STANLEY JDirectorDec 10Option Exercise5.944,95429,4279,013Dec 14 04:52 PM
MERESMAN STANLEY JDirectorDec 10Sale125.444,954621,4304,059Dec 14 04:52 PM
CLARK IAN TDirectorDec 03Option Exercise4.182,69011,2447,333Dec 07 05:01 PM
CLARK IAN TDirectorDec 03Sale120.002,690322,8004,643Dec 07 05:01 PM
CLARK IAN TDirectorNov 25Option Exercise4.185382,2495,181Nov 27 02:48 PM
CLARK IAN TDirectorNov 25Sale113.2853860,9454,643Nov 27 02:48 PM
MERESMAN STANLEY JDirectorNov 10Option Exercise5.945,00029,7009,059Nov 12 05:07 PM
MERESMAN STANLEY JDirectorNov 10Sale110.305,000551,5004,059Nov 12 05:07 PM
CLARK IAN TDirectorNov 03Option Exercise4.182,69011,2447,333Nov 05 05:32 PM
CLARK IAN TDirectorNov 03Sale105.282,690283,2034,643Nov 05 05:32 PM
Talasaz AmirAliChairman, President and COOOct 27Sale107.1875,8518,129,541620,800Oct 27 06:08 PM
CLARK IAN TDirectorOct 26Option Exercise4.185382,2495,181Oct 28 04:32 PM
CLARK IAN TDirectorOct 26Sale104.0353855,9684,643Oct 28 04:32 PM
Talasaz AmirAliChairman, President and COOOct 26Sale105.024,613484,472696,651Oct 27 06:08 PM
Talasaz AmirAliChairman, President and COOOct 23Sale105.1513,1361,381,315701,264Oct 27 06:08 PM
Kaul SamirDirectorOct 16Sale101.8810,0001,018,79351,943Oct 20 04:20 PM
Talasaz AmirAliChairman, President and COOOct 16Sale102.4423,4002,397,132714,400Oct 20 04:20 PM
MERESMAN STANLEY JDirectorOct 12Option Exercise5.945,00029,7009,059Oct 14 04:48 PM
MERESMAN STANLEY JDirectorOct 12Sale109.375,000546,8504,059Oct 14 04:48 PM
SVF Bluebird (Cayman) Ltd10% OwnerOct 09Sale101.087,000,000707,574,0007,037,960Oct 13 06:40 PM
CLARK IAN TDirectorOct 05Option Exercise4.182,69011,2447,333Oct 05 08:55 PM
CLARK IAN TDirectorOct 05Sale108.502,690291,8654,643Oct 05 08:55 PM
CLARK IAN TDirectorSep 25Option Exercise4.185382,2495,181Oct 05 08:55 PM
CLARK IAN TDirectorSep 25Sale106.2453857,1574,643Oct 05 08:55 PM
Talasaz AmirAliChairman, President and COOSep 25Sale110.7175,0008,303,3752,539,532Sep 29 05:01 PM
Eltoukhy HelmyChief Executive OfficerSep 18Option Exercise4.1813,63056,9732,884,952Sep 22 04:39 PM
Eltoukhy HelmyChief Executive OfficerSep 18Sale102.0965,4226,679,0622,819,530Sep 22 04:39 PM
Eltoukhy HelmyChief Executive OfficerSep 17Option Exercise4.1842,921179,4103,077,343Sep 17 09:10 PM
Kaul SamirDirectorSep 17Sale100.8310,0001,008,26461,943Sep 21 05:18 PM
Eltoukhy HelmyChief Executive OfficerSep 17Sale100.59206,02120,722,6362,871,322Sep 17 09:10 PM
Eltoukhy HelmyChief Executive OfficerSep 16Option Exercise4.1845,523190,2863,252,931Sep 17 09:10 PM
Eltoukhy HelmyChief Executive OfficerSep 16Sale103.92218,50922,707,9333,034,422Sep 17 09:10 PM
Eltoukhy HelmyChief Executive OfficerSep 15Option Exercise4.1822,92695,8313,317,456Sep 17 09:10 PM
Eltoukhy HelmyChief Executive OfficerSep 15Sale103.22110,04811,359,0633,207,408Sep 17 09:10 PM
MERESMAN STANLEY JDirectorSep 10Option Exercise5.945,00029,7009,059Sep 14 05:06 PM
MERESMAN STANLEY JDirectorSep 10Sale94.225,000471,1004,059Sep 14 05:06 PM
CLARK IAN TDirectorSep 08Option Exercise4.189,14638,23013,789Sep 10 05:24 PM
CLARK IAN TDirectorSep 08Sale89.259,146816,2474,643Sep 10 05:24 PM
Talasaz AmirAliChairman, President and COOSep 02Sale94.1575,0007,060,9612,614,532Sep 04 05:20 PM
BERTOCCI DEREK AChief Financial OfficerSep 01Sale93.9430,1002,827,4546,373Sep 03 05:13 PM
BERTOCCI DEREK AChief Financial OfficerAug 24Option Exercise4.829,99248,19346,465Aug 26 04:57 PM
BERTOCCI DEREK AChief Financial OfficerAug 24Sale94.399,992943,10236,473Aug 26 04:57 PM